申请人:Schoenfeld Ryan Craig
公开号:US20120009144A1
公开(公告)日:2012-01-12
Compounds having the formula I wherein R
1
, R
2
, R
3
and X are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
具有公式I的化合物,其中R1、R2、R3和X的定义如本文所述,是丙型肝炎病毒NS5b聚合酶抑制剂。还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。